Sunlight, lack of antioxidants tied to eye disease

By Amy Norton

NEW YORK (Reuters Health) - A combination of sunlight exposure and low blood levels of antioxidants may make older adults more vulnerable to a common vision-robbing disease called age-related macular degeneration, or AMD, researchers have found.

In a study of older adults from seven European countries, investigators found that among those with relatively low antioxidant levels, sun exposure was linked to an increased risk of advanced AMD. There was no such link seen in people with high antioxidant levels.

AMD is the leading cause of vision loss in older adults; it arises from gradual damage to the macula, a structure on the retina that allows for seeing fine detail.

The retina is the light-sensitive tissue at the back of the eye, and while much of the sun’s UV radiation is absorbed by outer eye structures, the retina is exposed to visible light — in particular, blue light.

Studies have, however, generally failed to find a connection between sun exposure and AMD risk.

The new findings are the first to suggest that sun exposure may raise AMD risk in people with low antioxidant levels, according to lead researcher Dr. Astrid Fletcher, a professor at the London School of Hygiene & Tropical Medicine in the UK.

Fletcher and colleagues found that among the one-quarter of study participants with the lowest total antioxidant levels, the risk of AMD rose in tandem with their long-term exposure to blue light from the sun.

Lab research indicates that antioxidants like vitamins C and E, zinc and lutein are important in protecting the retina from the toxic effects of light, Fletcher told Reuters Health. So, she explained, it is biologically plausible that the combination of high sun exposure and low antioxidant levels contributes to AMD risk.  Continued…


Related Posts:

NEW YORK (Reuters Health) - In the large Women’s Antioxidant Cardiovascular Study, participants who took beta carotene, vitamin C, vitamin E, or a combination of supplements had no significant reductions in their risk of cancer. The clinical trial, which involved 7,627 women who were followed for an average of 9.4 years, was conducted by Dr. Jennifer

Full Post: No cancer risk reductions seen with antioxidants

By Anne Harding NEW YORK (Reuters Health) - People who suffer from winter depression known as “seasonal affective disorder” or SAD — or the less severe but more common “winter blues” — shouldn’t seek relief in a tanning bed or booth, a leading expert on light therapy warns. SAD is often treated with daily sessions of exposure

Full Post: Tanning no cure for seasonal depression

By Will Dunham WASHINGTON (Reuters) - Beta carotene, vitamin C and vitamin E supplements taken for years failed to lower overall cancer risk in the latest study to cast doubt on the possibility that such dietary supplements can prevent cancer. The findings, published on Tuesday in the Journal of the National Cancer Institute, followed two other important

Full Post: Antioxidants fail again in cancer prevention study

LONDON (Reuters) - Doctors should not routinely give aspirin to people with diabetes to help guard against a heart attack or stroke, a British study found on Friday. While it was effective for those who had already developed heart disease or suffered a stroke, regular aspirin offered no benefit for patients with diabetes and a common

Full Post: Aspirin no heart protection for diabetics: study

By Anthony J. Brown, MD NEW YORK (Reuters Health) - As levels of parathyroid hormone rise, so does the risk of falls in older, well-functioning men and women with diabetes, according to findings from the Health, Aging and Body Composition (Health ABC) Study. Results from a number of studies have suggested that high levels of parathyroid hormone

Full Post: Hormone linked to falls in older diabetic adults

Site Navigation

Most Read